Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T, Sahm F, Blaes J, Osswald M, Rübmann P, Milford D, Urban S, Jestaedt L, Heiland S, Bendszus M, Hertenstein A, Pfenning PN, Ruiz de Almodóvar C, Wick A, Winkler F, von Deimling A, Platten M, Wick W, Weiler M.
Kessler T, et al. Among authors: weiler m.
Oncotarget. 2015 Oct 13;6(31):31050-68. doi: 10.18632/oncotarget.2910.
Oncotarget. 2015.
PMID: 25682871
Free PMC article.